Canada markets close in 4 hours 19 minutes

Elanco Animal Health Incorporated (ELAN)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
13.55+0.08 (+0.59%)
As of 11:41AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.66B
Enterprise Value 12.08B
Trailing P/E N/A
Forward P/E 14.18
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.50
Price/Book (mrq)1.07
Enterprise Value/Revenue 2.73
Enterprise Value/EBITDA -53.92

Trading Information

Stock Price History

Beta (5Y Monthly) 1.30
52-Week Change 344.68%
S&P500 52-Week Change 322.43%
52 Week High 316.88
52 Week Low 37.88
50-Day Moving Average 315.13
200-Day Moving Average 313.11

Share Statistics

Avg Vol (3 month) 34.16M
Avg Vol (10 day) 34.17M
Shares Outstanding 5494.1M
Implied Shares Outstanding 6494.1M
Float 8490.51M
% Held by Insiders 10.65%
% Held by Institutions 198.85%
Shares Short (Apr 15, 2024) 415.52M
Short Ratio (Apr 15, 2024) 44.27
Short % of Float (Apr 15, 2024) 45.04%
Short % of Shares Outstanding (Apr 15, 2024) 43.14%
Shares Short (prior month Mar 15, 2024) 412.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -27.87%
Operating Margin (ttm)1.64%

Management Effectiveness

Return on Assets (ttm)1.39%
Return on Equity (ttm)-18.22%

Income Statement

Revenue (ttm)4.42B
Revenue Per Share (ttm)8.97
Quarterly Revenue Growth (yoy)5.10%
Gross Profit (ttm)N/A
EBITDA 973M
Net Income Avi to Common (ttm)-1.23B
Diluted EPS (ttm)-2.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)352M
Total Cash Per Share (mrq)0.71
Total Debt (mrq)5.92B
Total Debt/Equity (mrq)95.07%
Current Ratio (mrq)2.74
Book Value Per Share (mrq)12.63

Cash Flow Statement

Operating Cash Flow (ttm)271M
Levered Free Cash Flow (ttm)388M